Filing Details
- Accession Number:
- 0001562180-19-000861
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 18:34:23
- Reporting Period:
- 2019-02-06
- Accepted Time:
- 2019-02-08 18:34:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1680628 | Jason Haddock | C/O Array Biopharma, 3200 Walnut St Boulder CO 80301 | Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-06 | 11,712 | $20.00 | 30,059 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-02-07 | 85,000 | $3.77 | 115,059 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-07 | 85,000 | $22.05 | 30,059 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-07 | 85,000 | $0.00 | 85,000 | $3.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 404,450 | 2026-07-28 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $22.00 to $22.12. Details of actual prices for shares sold are available from the Issuer upon request.
- The options vest in four equal annual installments beginning on July 28, 2017.
Billionaire Hedge Funds
